GCTK — GlucoTrack Cashflow Statement
0.000.00%
Annual cashflow statement for GlucoTrack, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.07 | -4.43 | -7.1 | -22.6 | -19.4 |
| Depreciation | |||||
| Non-Cash Items | 0.309 | 0.499 | 0.336 | 10 | 3.9 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.053 | 0.184 | 0.19 | 0.067 | 0.209 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.77 | -3.73 | -6.56 | -12.5 | -15.2 |
| Capital Expenditures | -0.005 | -0.001 | 0 | -0.104 | -0.096 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.004 | 0.002 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.001 | 0.001 | 0 | -0.104 | -0.096 |
| Financing Cash Flow Items | — | — | — | — | 3.54 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | — | 8.73 | 13.7 | 17 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.77 | -3.78 | 2.17 | 1.13 | 1.76 |